These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 30674775)

  • 1. Inquiry into some gap among oseltamivir use and severe abnormal behavior in Japanese children and adolescents with influenza.
    Ohkusa Y; Sugawara T; Taniguchi K; Miyazaki C; Momoi MY; Okabe N
    Drug Discov Ther; 2018; 12(6):381-383. PubMed ID: 30674775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of moderately abnormal behavior and administered neuraminidase inhibitors.
    Sugawara T; Ohkusa Y; Taniguchi K; Miyazaki C; Momoi MY; Okabe N
    Drug Discov Ther; 2020 Mar; 14(1):50-53. PubMed ID: 32101820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of severe abnormal behavior and acetaminophen with/without neuraminidase inhibitors.
    Sugawara T; Ohkusa Y; Taniguchi K; Miyazaki C; Momoi M; Okabe N
    J Infect Chemother; 2019 Jun; 25(6):423-426. PubMed ID: 30744989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical effectiveness of four neuraminidase inhibitors (oseltamivir, zanamivir, laninamivir, and peramivir) for children with influenza A and B in the 2014-2015 to 2016-2017 influenza seasons in Japan.
    Ishiguro N; Koseki N; Kaiho M; Ariga T; Kikuta H; Oba K; Togashi T; Morita K; Inagawa A; Okamura A; Yamazaki S; Shida S; Konno M; Kawamura N; Ishizaka A; Takada K; Tsubakihara K; Nagano N; Shibata M; Furuyama H; Matsuzono Y; Koike A; Murashita M; Hatae Y; Arioka H; Yamanaka T; Watanabe T; Tabata Y; Kumita Y; Hazama K; Akutsu Y; Aoyagi H; Tobise C; Azuma K; Yasoshima K; Sawada Y; Uetsuji K; Tsuchida A; Tsuchiyama A; Yasuda K; Odagawa Y; Yoshioka M
    J Infect Chemother; 2018 Jun; 24(6):449-457. PubMed ID: 29487035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical effectiveness of neuraminidase inhibitors--oseltamivir, zanamivir, laninamivir, and peramivir--for treatment of influenza A(H3N2) and A(H1N1)pdm09 infection: an observational study in the 2010-2011 influenza season in Japan.
    Shobugawa Y; Saito R; Sato I; Kawashima T; Dapat C; Dapat IC; Kondo H; Suzuki Y; Saito K; Suzuki H
    J Infect Chemother; 2012 Dec; 18(6):858-64. PubMed ID: 22644080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of the influenza virus circulating in the Japanese 2013-2014 season.
    Ikematsu H; Kawai N; Iwaki N; Kashiwagi S
    J Infect Chemother; 2015 Sep; 21(9):634-8. PubMed ID: 26096495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of peramivir and oseltamivir on the rise in platelet count in patients with or without proven influenza
.
    Kim YG; Ko SY; Lee SW
    Int J Clin Pharmacol Ther; 2019 Mar; 57(3):152-159. PubMed ID: 30526812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oseltamivir phosphate-Lifting the restriction on its use to treat teenagers with influenza in Japan.
    Takeuchi S; Tetsuhashi M; Sato D
    Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):434-436. PubMed ID: 30834626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal behavior during influenza in Japan during the last seven seasons: 2006-2007 to 2012-2013.
    Nakamura Y; Sugawara T; Ohkusa Y; Taniguchi K; Miyazaki C; Momoi M; Okabe N
    J Infect Chemother; 2014 Dec; 20(12):789-93. PubMed ID: 25284815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical effects of oseltamivir, zanamivir, laninamivir and peramivir on seasonal influenza infection in outpatients in Japan during the winter of 2012-2013.
    Takemoto Y; Asai T; Ikezoe I; Yano T; Ichikawa M; Miyagawa S; Matsumoto J
    Chemotherapy; 2013; 59(5):373-8. PubMed ID: 24821568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oseltamivir use and severe abnormal behavior in Japanese children and adolescents with influenza: Is a self-controlled case series study applicable?
    Fukushima W; Ozasa K; Okumura A; Mori M; Hosoya M; Nakano T; Tanabe T; Yamaguchi N; Suzuki H; Mori M; Hatayama H; Ochiai H; Kondo K; Ito K; Ohfuji S; Nakamura Y; Hirota Y
    Vaccine; 2017 Aug; 35(36):4817-4824. PubMed ID: 28818475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro neuraminidase inhibitory activities of four neuraminidase inhibitors against influenza viruses isolated in the 2010-2011 season in Japan.
    Ikematsu H; Kawai N; Kashiwagi S
    J Infect Chemother; 2012 Aug; 18(4):529-33. PubMed ID: 22370919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Efficacy of Intravenous Peramivir and Oral Oseltamivir for the Treatment of Influenza: Systematic Review and Meta-Analysis.
    Lee J; Park JH; Jwa H; Kim YH
    Yonsei Med J; 2017 Jul; 58(4):778-785. PubMed ID: 28540991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the binding affinities of peramivir and oseltamivir carboxylate to the neuraminidase enzyme.
    Bantia S; Upshaw R; Babu YS
    Antiviral Res; 2011 Sep; 91(3):288-91. PubMed ID: 21722670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe abnormal behavior incidence after administration of neuraminidase inhibitors using the national database of medical claims.
    Nakamura Y; Sugawara T; Ohkusa Y; Taniguchi K; Miyazaki C; Momoi M; Okabe N
    J Infect Chemother; 2018 Mar; 24(3):177-181. PubMed ID: 29273435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuraminidase inhibitors for preventing and treating influenza in children.
    Matheson NJ; Symmonds-Abrahams M; Sheikh A; Shepperd S; Harnden A
    Cochrane Database Syst Rev; 2003; (3):CD002744. PubMed ID: 12917931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of influenza virus in the Japanese 2012-2013 season.
    Ikematsu H; Kawai N; Iwaki N; Kashiwagi S
    J Infect Chemother; 2015 Jan; 21(1):39-42. PubMed ID: 25277670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends of neuraminidase inhibitors use in children with influenza related respiratory infections.
    Uda K; Okubo Y; Shoji K; Miyairi I; Morisaki N; Michihata N; Matsui H; Fushimi K; Yasunaga H
    Pediatr Pulmonol; 2018 Jun; 53(6):802-808. PubMed ID: 29673121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peramivir: an intravenous neuraminidase inhibitor for the treatment of 2009 H1N1 influenza.
    Mancuso CE; Gabay MP; Steinke LM; Vanosdol SJ
    Ann Pharmacother; 2010; 44(7-8):1240-9. PubMed ID: 20516360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuraminidase inhibitor susceptibility profile of pandemic and seasonal influenza viruses during the 2009-2010 and 2010-2011 influenza seasons in Japan.
    Dapat C; Kondo H; Dapat IC; Baranovich T; Suzuki Y; Shobugawa Y; Saito K; Saito R; Suzuki H
    Antiviral Res; 2013 Sep; 99(3):261-9. PubMed ID: 23791870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.